Clinical Trials
Discover the future of medicine today. Yale Medicine currently offers 692 active clinical trials across our hospitals and care centers, providing our patients with early access to many of the world’s most advanced therapies. Yale Center for Clinical Investigation (YCCI) supports, coordinates, and oversees clinical trials, ensuring the safety of trial volunteers.
For more information about cancer-related trials, call us at 203-785-5702. For all other trials, call 877-978-8343.
9 Results
- Thyroid & Other Endocrine Cancers
A Phase 1, Open-label, Multicenter, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of KQB168 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Malignancies
- Colorectal Cancer
- Stomach & Esophagus
- Kidney Cancer
- Head & Neck Cancers
- Lung Cancer
- Thyroid & Other Endocrine Cancers
- Phase 1 Cancers
- Gynecological Cancers
A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors
- Colorectal Cancer
- Stomach & Esophagus
- Head & Neck Cancers
- Lung Cancer
- Thyroid & Other Endocrine Cancers
- Phase 1 Cancers
- Breast Cancer
A Phase 3, Randomized, Multicenter, Open-Label Study of IDRX-42 (GSK6042981) Versus Sunitinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) After Imatinib Therapy (StrateGIST 3)
- Stomach & Esophagus
- Thyroid & Other Endocrine Cancers
A Phase III Study of Targeted Therapy vs. Chemotherapy in Patients with Thyroid Cancer
- Thyroid & Other Endocrine Cancers
- Gender:All Genders
- Age:18 years and older
An Open-label, Phase 1a/b, Multicenter Study of ZL-6201 to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy in Participants With Sarcoma and Selected Solid Tumors
- Colorectal Cancer
- Stomach & Esophagus
- Head & Neck Cancers
- Liver Cancer
- Lung Cancer
- Gastrointestinal Cancers
- Pancreatic Cancer
- Thyroid & Other Endocrine Cancers
- Phase 1 Cancers
- Breast Cancer
Endometrium and Metabolism
- Thyroid & Other Endocrine Cancers
- Gynecological Cancers
First-In-Human, Open-Label, Dose Escalation and Expansion Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of GEN1106 in Participants With Solid Tumors
- Stomach & Esophagus
- Head & Neck Cancers
- Lung Cancer
- Bladder Cancer
- Thyroid & Other Endocrine Cancers
- Phase 1 Cancers
- Breast Cancer
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
- Thyroid & Other Endocrine Cancers
- Pancreatic Cancer
The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
- Sarcoma Cancers
- Brain & Other Nervous System Cancers
- Eye Cancers
- Kidney Cancer
- Leukemia & Hematologic Cancers
- Liver Cancer
- Gastrointestinal Cancers
- Thyroid & Other Endocrine Cancers
- Gynecological Cancers
- Male Genital Cancers
- Lung Cancer
- Skin Cancers & Melanoma
- Bladder Cancer
- Colorectal Cancer
- Pediatric Cancers
- Lymphoma